MedPath

Efficacy of MASPORT in Blepharospasm

Phase 3
Recruiting
Conditions
Benign Essential Blepharospasm (BEB).
Blepharospasm
G24.5
Registration Number
IRCT20240216061023N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
19
Inclusion Criteria

Clinically diagnosed with BEB
Without prior BTX-A injection in the previous 6 month
History of previous eyelid surgery

Exclusion Criteria

pregnancy or lactation
secondary causes of Blepharospasm
History of disorders of the neuromuscular junction like myasthenia gravis, Eaton-Lambert Syndrome, and psychological instability
prescription of antispastic, muscle relaxants or medications affecting neuromuscular junction transmission such as aminoglycosides

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.